SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20700799
Source:
http://linkedlifedata.com/resource/pubmed/id/20700799
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0087111
,
umls-concept:C0796392
,
umls-concept:C1554888
pubmed:issue
4
pubmed:dateCreated
2010-8-11
pubmed:abstractText
To evaluate the efficacy of intravitreal bevacizumab (IVB) in eyes with polypoidal choroidal vasculopathy (PCV).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0044652
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized
,
http://linkedlifedata.com/resource/pubmed/chemical/VEGFA protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
,
http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1613-2246
pubmed:author
pubmed-author:OotoSotaroS
,
pubmed-author:OtaniAtsushiA
,
pubmed-author:TamuraHiroshiH
,
pubmed-author:TsujikawaAkitakaA
,
pubmed-author:YamashiroKenjiK
,
pubmed-author:YoshimuraNagahisaN
pubmed:issnType
Electronic
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
310-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20700799-Aged
,
pubmed-meshheading:20700799-Aged, 80 and over
,
pubmed-meshheading:20700799-Angiogenesis Inhibitors
,
pubmed-meshheading:20700799-Antibodies, Monoclonal
,
pubmed-meshheading:20700799-Antibodies, Monoclonal, Humanized
,
pubmed-meshheading:20700799-Choroid
,
pubmed-meshheading:20700799-Choroid Diseases
,
pubmed-meshheading:20700799-Female
,
pubmed-meshheading:20700799-Fluorescein Angiography
,
pubmed-meshheading:20700799-Follow-Up Studies
,
pubmed-meshheading:20700799-Humans
,
pubmed-meshheading:20700799-Injections
,
pubmed-meshheading:20700799-Male
,
pubmed-meshheading:20700799-Middle Aged
,
pubmed-meshheading:20700799-Peripheral Vascular Diseases
,
pubmed-meshheading:20700799-Retreatment
,
pubmed-meshheading:20700799-Tomography, Optical Coherence
,
pubmed-meshheading:20700799-Treatment Outcome
,
pubmed-meshheading:20700799-Vascular Endothelial Growth Factor A
,
pubmed-meshheading:20700799-Visual Acuity
,
pubmed-meshheading:20700799-Vitreous Body
pubmed:year
2010
pubmed:articleTitle
Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab.
pubmed:affiliation
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan. tujikawa@kuhp.kyoto-u.ac.jp
pubmed:publicationType
Journal Article